Pharma industry

US President Donald Trump reacts as he meets NATO Secretary General Mark Rutte (not pictured), in the Oval Office at the White House in Washington, DC, US, March 13, 2025. Photo: REUTERS/Evelyn Hockstein/File Photo
USA

Trump signs healthcare executive order that includes a win for pharma companies

Drugmakers have been pushing to delay the timeline under which medications become eligible for price negotiations by four years for small molecule drugs, which are primarily pills and account for...

Pharma industry in labour turmoil amid ‘outsider instigation’
Economy

Pharma industry in labour turmoil amid ‘outsider instigation’

Representational Image. Bangladesh’s overall export of pharmaceutical products increased from $103 million to $130 million in FY19 from FY18. Photo: Reuters
Industry

Pharma faces soaring input costs, dollar crisis: Entrepreneurs

Representational image/Collected
Economy

Pharma industry facing tough time due to high prices of materials, energy and transportation: Owners

As medicine prices increase, the poorest one-fifth of households will face a difficult tradeoff between life-saving medicines and other basic needs. Photo: Mumit M
Panorama

Pharma industry needs to prepare for headwinds

Sketch: TBS
Thoughts

LDC graduation: What lies ahead for the pharmaceutical sector of Bangladesh?

Shelves displaying medicines are seen at a pharmacy in Shanghai, China, November 27, 2015. Photo :Reuters
China

China to strengthen anti-monopoly efforts in pharma industry

Therapeutics Bangladesh gets a kiss of life
Economy

Therapeutics Bangladesh gets a kiss of life

TBS Infograph
Economy

Pandemic a boon for some pharma, bane for many

Global pharma shares slide as Biden backs Covid-19 vaccine IP waiver
Global Economy

Global pharma shares slide as Biden backs Covid-19 vaccine IP waiver

Representational image. PHOTO: Reuters
Industry

API park to be ready by June for pharma industry

Pharma gets pandemic boost
Industry

Pharma gets pandemic boost

Kaiser Kabir, chief executive officer and managing director of Renata Limited. Illustration: TBS
Panorama

Bangladesh must upgrade capacity to develop high value-added medicines: Kaiser Kabir